Rocket Lab (NASDAQ:RKLB) Stock Gets Price Target Trim from Citizens Jmp

Rocket Lab (NASDAQ:RKLB) had its price target trimmed by Citizens Jmp from $130.00 to $90.00 in a research note issued to investors on Friday morning,Benzinga reports. They currently have a market outperform rating on the rocket manufacturer’s stock.

RKLB has been the topic of several other research reports. TD Cowen reissued a “buy” rating and issued a $90.00 target price on shares of Rocket Lab in a research note on Thursday. KGI Securities upgraded Rocket Lab from a “neutral” rating to an “outperform” rating and set a $107.00 target price on the stock in a report on Monday, July 27th. Roth Capital restated a “buy” rating on shares of Rocket Lab in a research report on Thursday. Cantor Fitzgerald restated a “mixed” rating and set a $122.00 target price on shares of Rocket Lab in a research report on Thursday. Finally, Raymond James Financial started coverage on Rocket Lab in a research note on Friday, September 11th. They issued an “outperform” rating and a $80.00 price target for the company. Three research analysts have rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $102.05.

Rocket Lab Stock Performance

RKLB stock opened at $50.84 on Friday. The business’s fifty day moving average is $68.86 and its 200-day moving average is $84.24. The company has a quick ratio of 4.98, a current ratio of 5.48 and a debt-to-equity ratio of 0.01. The company has a market cap of $30.42 billion, a P/E ratio of -188.29 and a beta of 2.93. Rocket Lab has a twelve month low of $37.57 and a twelve month high of $151.00.

Rocket Lab (NASDAQ:RKLB) last posted its quarterly earnings results on Monday, August 10th. The rocket manufacturer reported ($0.08) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.06) by ($0.02). Rocket Lab had a negative return on equity of 6.48% and a negative net margin of 21.51%. The company had revenue of $234.07 million during the quarter, compared to the consensus estimate of $231.62 million. Equities research analysts forecast that Rocket Lab will post -0.20 EPS for the current year.

Insider Activity at Rocket Lab

In other news, insider Marvin Clevenger sold 15,051 shares of Rocket Lab stock in a transaction on Monday, August 24th. The shares were sold at an average price of $69.63, for a total transaction of $1,048,001.13. Following the transaction, the insider directly owned 458,924 shares of the company’s stock, valued at $31,954,878.12. This trade represents a 3.18% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CAO Agostino Ricupati sold 669 shares of the business’s stock in a transaction on Monday, August 24th. The shares were sold at an average price of $69.63, for a total transaction of $46,582.47. Following the completion of the transaction, the chief accounting officer directly owned 26,863 shares of the company’s stock, valued at $1,870,470.69. This trade represents a 2.43% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last quarter, insiders sold 400,749 shares of company stock valued at $26,964,474. 8.40% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in RKLB. Signature Resources Capital Management LLC acquired a new stake in Rocket Lab in the 3rd quarter valued at approximately $53,000. SteelPeak Wealth LLC lifted its stake in Rocket Lab by 53.7% in the 3rd quarter. SteelPeak Wealth LLC now owns 6,511 shares of the rocket manufacturer’s stock valued at $454,000 after acquiring an additional 2,275 shares in the last quarter. Eagle Strategies LLC lifted its stake in Rocket Lab by 40.7% in the 3rd quarter. Eagle Strategies LLC now owns 9,404 shares of the rocket manufacturer’s stock valued at $655,000 after acquiring an additional 2,721 shares in the last quarter. TB Alternative Assets Ltd. boosted its position in Rocket Lab by 508.5% during the 3rd quarter. TB Alternative Assets Ltd. now owns 320,703 shares of the rocket manufacturer’s stock worth $22,347,000 after acquiring an additional 268,000 shares during the last quarter. Finally, Cornerstone Enterprises LLC boosted its position in Rocket Lab by 74.4% during the 3rd quarter. Cornerstone Enterprises LLC now owns 6,122 shares of the rocket manufacturer’s stock worth $427,000 after acquiring an additional 2,611 shares during the last quarter. 71.78% of the stock is owned by institutional investors and hedge funds.

Rocket Lab News Summary

Here are the key news stories impacting Rocket Lab this week:

• Positive Sentiment: Rocket Lab continues to benefit from strong existing operations, including its Electron launch business, satellite systems activities and defense contracts. The company reported record second-quarter revenue of approximately $234 million, up 62% year over year, and maintains a backlog of roughly $2.36 billion. Rocket Lab Still Has a $2.4B Backlog While Neutron Waits
• Positive Sentiment: Despite reducing estimates, several analysts remain bullish. Citizens JMP lowered its target to $90 from $130 but retained a Market Outperform rating; TD Cowen maintained a Buy rating and $90 target, while Cantor Fitzgerald and Roth Capital also remained constructive. Rocket Lab analyst coverage
• Neutral Sentiment: Management said the manufacturing issue has been addressed and that additional testing is expected before a launch date is finalized. The company is prioritizing reliability and quality, but investors must now wait longer for evidence that Neutron can expand Rocket Lab into the larger medium-lift launch market. Rocket Lab discusses Neutron program update and manufacturing challenges
• Negative Sentiment: The delay is especially damaging because Neutron is central to Rocket Lab’s growth and planned path toward adjusted EBITDA profitability. Repeated schedule slips are increasing execution concerns, extending cash-burn risk and postponing potential launch revenue. Rocket Lab pushes Neutron rocket debut flight to 2027
• Negative Sentiment: Technical momentum has also weakened after the sell-off pushed RKLB below the closely watched $60 support level and below its major moving averages. Although Wall Street’s consensus remains broadly positive, lower price targets and renewed skepticism have added pressure to the stock.

Rocket Lab Company Profile

Rocket Lab USA, Inc is a space and defense company that develops and operates launch vehicles, spacecraft, satellite components and related space systems. The company serves government, commercial and scientific customers seeking access to orbit and other space-based capabilities.

Rocket Lab’s launch business is centered on Electron, a small orbital launch vehicle designed to carry satellites and other payloads into low Earth orbit. The company also develops specialized launch and hypersonic test services through programs such as HASTE, while its Neutron vehicle is intended to provide larger payload capacity and support future commercial and government missions.

Through its space systems business, Rocket Lab produces satellite platforms, flight computers, power systems, solar cells, reaction wheels, separation systems, radios and other components used in spacecraft.